RTW Investments has a series C for the UT Southwestern and Gladstone Institutes spinout, which will progress its lead asset into the clinic.

Tenaya Therapeutics, a US-based developer of therapies for heart disease exploiting Gladstone Institutes and University of Texas Southwestern Medical Center research, collected $106m in a series C round yesterday led by RTW Investments. GV, a corporate venturing arm of technology conglomerate Alphabet, also took part in the round, as did RA Capital Management, Fidelity, Column…

The rest of this content is only accessible to University Venturing: News, Data and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.